Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine

Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine

Source: 
Forbes
snippet: 

Novavax, a biotech company focused on developing vaccines against infectious diseases, announced Monday that it is beginning a phase 1 clinical trial of its Covid-19 vaccine candidate in Australia. Results of the trial are expected in July 2020.